Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

scientific article

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1365-2893.2003.00440.X
P698PubMed publication ID12823596
P5875ResearchGate publication ID10692888

P50authorHubert G.M. NiestersQ44180267
P2093author name stringJanssen HL
de Man RA
Schalm SW
van Nunen AB
van Zonneveld M
P2860cites workReduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study GroupQ28239283
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analoguesQ28373514
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.Q42541246
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.Q43580701
Vertical transmission of hepatitis B virus despite maternal lamivudine therapyQ43978530
Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspringQ45753331
P433issue4
P921main subjectHepatitis B virusQ6844
hepatitis BQ6853
lamivudineQ422631
P304page(s)294-297
P577publication date2003-07-01
P1433published inJournal of Viral HepatitisQ15749962
P1476titleLamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection
P478volume10